J. G. MILLS - Concepedia

Author

J. G. MILLS

Oxford Research Group

Also Known As

J G Mills, J. G. MILLS, J. G. Mills, J. Mills, J.G. Mills

Publications

319

Citations

H-Index

Concepts

All Affiliations

Oxford Research Group GlaxoSmithKline (Germany)Royal Hospital Haslar

About

J. G. MILLS is an author at Oxford Research Group specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	178
2	Pharmacology	4	4	178
3	Gastroenterology	3	3	139
4	Clinical Pharmacology	3	3	139
5	Anesthesia	2	2	115

J. G. MILLS

Publications

254

Citations

H-Index

Page 1

	Year	Citations
Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Nancy J. Johnson, E. J. S. Boyd, J. G. MILLS, Alimentary Pharmacology & Therapeutics Acute TreatmentMg Ranitidine Q.d.sEsophagusGastrointestinal PharmacologyMedicine	1989	88
Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration J. Heykants, A. Van Peer, Robert Woestenborghs, European Journal of Clinical Pharmacology Pharmacological StudyMedicineNeuropharmacologyOral AdministrationPharmacotherapy	1986	39
Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist. J. G. MILLS, P L Brunet, R R Griffiths, Gut Molecular PharmacologyHealthy SubjectsPharmacological StudyNew H2-receptor AntagonistMedicine	1982	27
Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study. Mark Deakin, Helen Glenny, John Ramage, Gut Intragastric AcidityGastric AcidityClinical Pharmacological StudyGastrointestinal PharmacologyPharmacology	1987	24
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime Lars Halvorsen, F I Lee, I C Wesdorp, Alimentary Pharmacology & Therapeutics	1989	17
Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo C. E. GRIMLEY, S Constantinides, C.C.L. Snell, Alimentary Pharmacology & Therapeutics	1997	16
Can higher doses of an H<sub>2</sub>‐receptor antagonist accelerate duodenal ulcer healing? M. C. Page, Lauren Lacey, J. G. MILLS, Alimentary Pharmacology & Therapeutics	1989	12
Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate R L McIsaac, Jonathan S. Dixon, J. G. MILLS, Alimentary Pharmacology & Therapeutics	1991	11
The pharmacology of histamine H2-receptor antagonists. J. G. MILLS, John R. Wood PubMed	1989	10
A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer John Primrose, Gavin Miller, Shaun R. Preston, Gut	1998	10

Page 1